Literature DB >> 20556404

TGF-beta1 improves cardiac performance via up-regulation of laminin receptor 37/67 in adult ventricular cardiomyocytes.

Sibylle Wenzel1, Kirsten Henning, Andreas Habbig, Svenja Forst, Rolf Schreckenberg, Jacqueline Heger, Hagen Maxeiner, Klaus-Dieter Schlüter.   

Abstract

TGF-beta1 plays an important role in cardiac fibrosis, apoptosis, induction of hypertrophy and contractile dysfunction. This study investigates whether TGF-beta1 plays a role in laminin receptor 37/67 (37/67 LR)-dependent regulation of cardiac performance. Therefore, isolated adult cardiomyocytes were stimulated with TGF-beta1, the expression of the 37/67 LR was determined and cell shortening was investigated on cells attached to a non-specific, serum-based attachment substrate or to specific, laminin-coated dishes. The role of the MAP kinases in TGF-beta1-dependent induction of the 37/67 LR was examined by addition of PD98059, SB202190 and SP600125. Finally, the expression of receptor mRNA was investigated in transgenic mice constitutively over-expressing TGF-beta1 and the relationship to distress score and lung wet weight-to-body weight was analysed. TGF-beta1 induced a significant increase of the 37/67 LR mRNA and protein expression. The cytokine induced p38 MAP kinase and JNK, but not ERK. Inhibition of either p38 MAP kinase or JNK attenuated the TGF-beta1-dependent increase in 37/67 LR expression. TGF-beta1 induced a loss of cell shortening in cells attached to a non-specific substrate, but not in cells on a pre-coated laminin matrix. Inhibition of JNK attenuated the protective effect of laminin receptor up-regulation on cardiac performance. Inhibition of p38 MAP kinase attenuated the depressive effect of TGF-beta1 on basal cell shortening. In transgenic mice over-expressing TGF-beta1 a strong induction of laminin receptor expression attenuated the severeness of the mice' symptoms. This study shows a new and protective role of TGF-beta1-dependent up-regulation of the 37/67 LR in cardiomyocytes in cardiac remodelling with increased laminin expression.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20556404     DOI: 10.1007/s00395-010-0108-1

Source DB:  PubMed          Journal:  Basic Res Cardiol        ISSN: 0300-8428            Impact factor:   17.165


  7 in total

Review 1.  The role of transforming growth factor (TGF)-β in the infarcted myocardium.

Authors:  Nikolaos G Frangogiannis
Journal:  J Thorac Dis       Date:  2017-03       Impact factor: 2.895

Review 2.  Looking into laminin receptor: critical discussion regarding the non-integrin 37/67-kDa laminin receptor/RPSA protein.

Authors:  Vincent DiGiacomo; Daniel Meruelo
Journal:  Biol Rev Camb Philos Soc       Date:  2015-01-28

Review 3.  Transforming growth factor-β in myocardial disease.

Authors:  Nikolaos G Frangogiannis
Journal:  Nat Rev Cardiol       Date:  2022-01-04       Impact factor: 32.419

4.  Oxidized low-density lipoprotein (oxLDL) affects load-free cell shortening of cardiomyocytes in a proprotein convertase subtilisin/kexin 9 (PCSK9)-dependent way.

Authors:  Klaus-Dieter Schlüter; Annemarie Wolf; Martin Weber; Rolf Schreckenberg; Rainer Schulz
Journal:  Basic Res Cardiol       Date:  2017-09-14       Impact factor: 17.165

5.  Angiotensin II and TGF-β1 Induce Alterations in Human Amniotic Fluid-Derived Mesenchymal Stem Cells Leading to Cardiomyogenic Differentiation Initiation.

Authors:  Monika Gasiūnienė; Gintautas Petkus; Dalius Matuzevičius; Dalius Navakauskas; Rūta Navakauskienė
Journal:  Int J Stem Cells       Date:  2019-07-31       Impact factor: 2.500

6.  Long pentraxin PTX3 exacerbates pressure overload-induced left ventricular dysfunction.

Authors:  Satoshi Suzuki; Tetsuro Shishido; Akira Funayama; Shunsuke Netsu; Mitsunori Ishino; Tatsuro Kitahara; Toshiki Sasaki; Shigehiko Katoh; Yoichiro Otaki; Tetsu Watanabe; Yoko Shibata; Alberto Mantovani; Yasuchika Takeishi; Isao Kubota
Journal:  PLoS One       Date:  2013-01-23       Impact factor: 3.240

Review 7.  The Role of the TGF-β Superfamily in Myocardial Infarction.

Authors:  Anis Hanna; Nikolaos G Frangogiannis
Journal:  Front Cardiovasc Med       Date:  2019-09-18
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.